In recent years, the rapid development of next-generation sequencing (NGS) technologies
has led to a significant reduction in sequencing cost with improved accuracy. In the area of …

BACKGROUND Lung cancer kills more people than any other cancer in the UK (5-year
survival< 13%). Early diagnosis can save lives. The USA-based National Lung Cancer …

Introduction In the randomized trial of standard-versus high-dose chemoradiotherapy for
locally advanced (LA) NSCLC (Radiation Therapy Oncology Group 0617), overall survival …

Aim Decreased cancer incidence and reported changes to clinical management indicate
that the COVID‐19 pandemic has delayed cancer diagnosis and treatment. This study aimed …

Introduction A randomized trial has demonstrated that lung cancer screening reduces
mortality. Identifying participant and program characteristics that influence the cost …

Introduction Lung cancer risk prediction models have the potential to make programs more
affordable; however, the economic evidence is limited. Methods Participants in the National …

The global burden of lung cancer has been increasing over the past years, and is still a
major threat to public health worldwide, leading to disabilities and premature mortality …

BACKGROUND: There is increasing concern regarding the financial burden of care on
cancer patients and their families. Medicare beneficiaries often have extensive comorbidities …

Objectives: This study assessed the cost-effectiveness of left ventricular assist devices
(LVADs) as destination therapy in ambulatory patients with advanced heart failure …

Background We studied trends in lung cancer treatment cost over time by phase of care,
treatment strategy, age, stage at diagnosis, and histology. Methods Using the Surveillance …